SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Birchview Capital GP, LLC (Last) (First) (Middle) 688 PINE STREET, SUITE D (Street) BURLINGTON VT 05401 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/22/2014	3. Issuer Name and Ticker or Trading Symbol METABOLIX, INC. [ MBLX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,000,000(1)	I	See footnote(2)(4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series B Convertible Preferred Stock	(3)	(3)	Common Stock	2,000(1)(3)	(3)	I	See footnote(2)(4)

1. Name and Address of Reporting Person* Birchview Capital GP, LLC (Last) (First) (Middle) 688 PINE STREET, SUITE D (Street) BURLINGTON VT 05401 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Birchview Capital, LP (Last) (First) (Middle) 688 PINE STREET, SUITE D (Street) BURLINGTON VT 05401 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Birchview Fund LLC (Last) (First) (Middle) 688 PINE STREET, SUITE D (Street) BURLINGTON VT 05401 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Birchview Partners, LLC (Last) (First) (Middle) 688 PINE STREET, SUITE D (Street) BURLINGTON VT 05401 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The reported securities are included within 2,000,000 units of Issuer securities (the "Units") purchased by Birchview Fund, LLC (the "Fund") for $0.50 per Unit pursuant to a Securities Purchase Agreement, dated August 4, 2014 by and among the Issuer, the reporting person and certain other qualified institutional and individual investors. Each Unit consists of one share of the Issuer's common stock, par value $0.01 per share ("Common Stock") and one one-thousandth (1/1,000) of a share of the Issuer's Series B Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock").

2. Birchview Partners, LLC (the "Manager") is a member of Birchview Capital GP, LLC (the "GP"), which is the general partner of Birchview Capital, LP (the "Investment Manager"), the investment Manager of the Fund. The Manager disclaims Section 16 beneficial ownership of the shares of Common Stock and Preferred Stock held by the Fund (collectively, the "Fund Shares") and this report shall not be deemed an admission that such reporting person is the beneficial owner of such Fund Shares, except to the extent of its pecuniary interest, if any, in the Fund Shares by virtue of its membership interest in the Fund. The GP and Investment Manager disclaim Section 16 beneficial ownership of the Fund Shares and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such Fund Shares, except to the extent of their pecuniary interest, if any, in the Fund Shares by virtue of their management fee interest in the Fund.

3. Each share of Preferred Stock will automatically convert into 1,000 shares of Common Stock upon the effectiveness of the filing of an amendment to the Issuer's charter to increase the number of shares of the Issuer's authorized Common Stock to not less than 150,000,000.

4. Matthew Strobeck, the sole member of the GP, serves as the representative of the GP, the Investment Manager and the Fund on the Issuer's board of directors.

Remarks:

This report shall not be deemed an admission by any of the reporting persons that they are or may be members of a "group" for purposes of Section 13(d). Exhibit 24.1- Power of Attorney, Exhibit 24.2 - Power of Attorney, Exhibit 24.3 - Power of Attorney and Exhibit 24.4 - Power of Attorney.

	/s/ Sarah P. Cecil, attorney-in-fact, BIRCHVIEW FUND, LLC	08/29/2014
	/s/ Sarah P. Cecil, attorney-in-fact, BIRCHVIEW CAPITAL, LP	08/29/2014
	/s/ Sarah P. Cecil, attorney-in-fact, BIRCHVIEW CAPITAL GP, LLC	08/29/2014
	/s/ Sarah P. Cecil, attorney-in-fact, BIRCHVIEW PARTNERS, LLC	08/29/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.